Jump to ContentJump to Main Navigation
FDA in the Twenty-First CenturyThe Challenges of Regulating Drugs and New Technologies$
Users without a subscription are not able to see the full content.

Holly Fernandez Lynch and I. Glenn Cohen

Print publication date: 2015

Print ISBN-13: 9780231171182

Published to Columbia Scholarship Online: May 2016

DOI: 10.7312/columbia/9780231171182.001.0001

Show Summary Details
Page of

PRINTED FROM COLUMBIA SCHOLARSHIP ONLINE (www.columbia.universitypressscholarship.com). (c) Copyright University of Minnesota Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in CUPSO for personal use.date: 29 July 2021

FDA’s Public Health Imperative

FDA’s Public Health Imperative

An Increased Role for Active Postmarket Analysis

Chapter:
(p.286) Chapter Fifteen FDA’s Public Health Imperative
Source:
FDA in the Twenty-First Century
Author(s):

Efthimios Parasidis

Publisher:
Columbia University Press
DOI:10.7312/columbia/9780231171182.003.0020

This chapter focuses on current and emerging issues related to post-market analysis of medical products. It argues that the future of the FDA as a public health agency is largely dependent on how well the agency leverages its mandate and resources to address the limitations of pre-market review and expand the instances in which post-market analysis is required.

Keywords:   FDA, Post-market surveillance, Sentinel System, Public Health, Big Data

Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .